Itzchak Angel

Title: Itzchak Angel: Innovator in Ubiquitination Inhibition

Introduction

Itzchak Angel, an accomplished inventor based in Ness Ziona, IL, has made significant contributions to the field of medicinal chemistry. With a focus on innovative solutions for treating viral infections and neurological disorders, his work has garnered attention within the scientific community.

Latest Patents

Angel holds a patent for "Pyrimidine derivatives as POSH and POSH-AP inhibitors." This groundbreaking invention involves pyrimidine derivatives that act as ubiquitination inhibitors. Specifically, they inhibit the ubiquitin ligase activity of POSH polypeptides, providing a novel approach to address various health conditions.

Career Highlights

Itzchak Angel is associated with Proteologics, Inc., a company dedicated to developing therapeutic solutions and advancing research in the field of proteomics. His work has played a critical role in fostering innovative therapies that contribute to improved health outcomes.

Collaborations

Throughout his career, Angel has collaborated with esteemed colleagues, including Philippe Nakache and Nurit Livnah. These partnerships have facilitated the exchange of ideas and knowledge, further driving the advancement of their collective research efforts.

Conclusion

In summary, Itzchak Angel stands out as a pivotal figure in the realm of medicinal chemistry, particularly in the development of ubiquitination inhibitors. His patent for pyrimidine derivatives symbolizes a significant step forward in treating viral infections and neurological disorders, promoting a brighter future for therapeutic research.